EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 30 January 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 3.96 for October-December, 2018 as against Tk. 3.62 for October-December, 2017; Consolidated EPS was Tk. 7.98 for July-December, 2018 as against Tk. 7.43 for July-December, 2017. Consolidated NOCFPS was Tk. 7.32 for July-December, 2018 as against Tk. 8.09 for July-December, 2017. Consolidated NAV per share was Tk. 77.90 as on December 31, 2018 and Tk. 73.28 as on June 30, 2018.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b00004005a93d
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.